1Molenaar P, Parsonage W A. Fundamental considerations of β-adrenoceptor subtypes in human heart failure [J]. Trends Pharmacol Sci, 2005, 26 (7):368-375.
2Cleland J G,Daubert J C,Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure[J]. N Engl J Med, 2005, 352(15):1539-1549.
3ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) [J]. J Am Coll Cardiol, 2005, 46(6):e1-82.
5Soon S R, Yong R,Chew Z H,et al. Pilot survey of the diagnosis and management of heart failure in primary care: a Singaporean perspective [J]. Ann Acad Med Singapore, 2004, 33 (4) :413-418.
10Van Bortel LM,Fici F,Mascagni F.Efficacy and tolerability of nebivolol compared with other antihypertensive drugs:a Metaanalysis.Am J Cardiovasc Drugs,2008,8(1):35-44.
